GL vs PACB · P/E 10, $10.26B cap vs rev $38.4M
Globe Life Inc (GL) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
GL does not have a complete income-statement cache yet.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
GL currently screens at market cap $10.26B and trailing P/E 10.1. PACB currently screens at market cap $387.1M.
Not investment advice. Open the GL and PACB stock pages for the full models.
Not investment advice.